Cargando…

Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE

OBJECTIVES: Antiphosphatidylserine/prothrombin complex antibodies (aPS/PT) are risk factors for thrombosis, yet further validation of their clinical relevance in different ethnic groups is required. We investigated the performance of aPS/PT of IgA/G/M isotypes among Sudanese and Swedish systemic lup...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbagir, Sahwa, Grosso, Giorgia, Mohammed, NasrEldeen A, Elshafie, Amir I, Elagib, Elnour M, Zickert, Agneta, Manivel, Vivek Anand, Pertsinidou, Eleftheria, Nur, Musa A. M, Gunnarsson, Iva, Rönnelid, Johan, Svenungsson, Elisabet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209767/ https://www.ncbi.nlm.nih.gov/pubmed/33957795 http://dx.doi.org/10.1177/09612033211014570

Ejemplares similares

High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients
por: Elbagir, Sahwa, et al.
Publicado: (2020)

Accumulation of antinuclear associated antibodies in circulating immune complexes is more prominent in SLE patients from Sudan than Sweden
por: Elbagir, Sahwa, et al.
Publicado: (2020)

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2022)

Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons
por: Elbagir, Sahwa, et al.
Publicado: (2020)

Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β(2) glycoprotein I domain 1 antibodies
por: Elbagir, S, et al.
Publicado: (2020)

Detection of Antiphosphatidylserine/Prothrombin Antibodies and Their Potential Diagnostic Value
por: Žigon, Polona, et al.
Publicado: (2013)

Takayasu Arteritis With Antiphosphatidylserine/Prothrombin Antibody-Positive Antiphospholipid Syndrome: Case Report and Literature Review
por: Fukui, Shoichi, et al.
Publicado: (2015)

Comment on: Sudanese and Swedish patients with systemic lupus erythematosus, immunological and clinical comparisons: reply
por: Elbagir, Sahwa, et al.
Publicado: (2020)

Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays
por: Tsutsumi, Akito, et al.
Publicado: (2006)

Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case–control study
por: Samuelsson, Isak, et al.
Publicado: (2021)

Antiphospholipid Antibodies in Lupus Nephritis
por: Parodis, Ioannis, et al.
Publicado: (2016)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
por: Oke, Vilija, et al.
Publicado: (2017)

Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations
por: Mobarrez, Fariborz, et al.
Publicado: (2016)

Antiphosphatidylserine Antibody as a Cause of Multiple Dural Venous Sinus Thromboses and ST-Elevation Myocardial Infarction
por: Varner, Chelsea Kathleen, et al.
Publicado: (2018)

Paratope diversity of anti-prothrombin antibodies
por: Cucnik, S, et al.
Publicado: (2003)

Role of early repeated renal biopsies in lupus nephritis
por: Zickert, A, et al.
Publicado: (2014)

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
por: Sohrabian, Azita, et al.
Publicado: (2019)

IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment
por: Zickert, Agneta, et al.
Publicado: (2015)

Efficacy and Safety of Rituximab Therapy for Lupus Nephritis Among SLE Female Patients; a Retrospective Hospital-Based Study
por: Abdelkarim Aloub, Khansa Osama, et al.
Publicado: (2022)

Association of anticardiolipin, antiphosphatidylserine, anti-β(2) glycoprotein I, and antiphosphatidylcholine autoantibodies with canine immune thrombocytopenia
por: Chen, Yu-Chen, et al.
Publicado: (2016)

Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up
por: Gerhardsson, Jakob, et al.
Publicado: (2015)

Interferon (IFN)-λ is a potential mediator in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2016)

Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE
por: Pavlovic, Mirjana, et al.
Publicado: (2010)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010)

Prothrombin fragment F1+2 in patients with antiphospholipid antibodies
por: Ambrozic, A, et al.
Publicado: (2004)

Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
por: Žigon, Polona, et al.
Publicado: (2015)

Kynurenine pathway is altered in patients with SLE and associated with severe fatigue
por: Åkesson, Karolina, et al.
Publicado: (2018)

B cell alterations during BAFF inhibition with belimumab in SLE
por: Ramsköld, Daniel, et al.
Publicado: (2018)

Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort study
por: Karlsson, Linnea, et al.
Publicado: (2023)

What to Expect When Expecting With Systemic Lupus Erythematosus (SLE): A Population‐Based Study of Maternal and Fetal Outcomes in SLE and Pre‐SLE
por: Arkema, Elizabeth V., et al.
Publicado: (2016)

Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort
por: Mullen, Michael T., et al.
Publicado: (2012)

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies
por: Radin, Massimo, et al.
Publicado: (2021)

Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
por: Stockfelt, Marit, et al.
Publicado: (2021)

Loss of antiphospholipid antibody positivity post-thrombosis in SLE
por: Khawaja, Muznay, et al.
Publicado: (2020)

Low frequency of phosphatidylserine/prothrombin complex antibodies in a cohort of patients with anticardiolipin antibodies and recent thrombosis
por: Locht, H
Publicado: (2003)

Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations
por: Wang, Chuan, et al.
Publicado: (2013)

Anti-type II collagen immune complex-induced granulocyte reactivity is associated with joint erosions in RA patients with anti-collagen antibodies
por: Manivel, Vivek Anand, et al.
Publicado: (2015)

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus
por: Oke, Vilija, et al.
Publicado: (2019)

Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response
por: Xu, Wenye, et al.
Publicado: (2022)

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rfh8rcqpsjj1u5m8v6a8mlvpnd